Skip to content

Repligen RGEN Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
1K

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's share-based compensation arrangement by share-based payment award, options, exercises in period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's share-based compensation arrangement by share-based payment award, options, exercises in period?
Repligen (RGEN) reported share-based compensation arrangement by share-based payment award, options, exercises in period of 0 in Q1 2026.
What does share-based compensation arrangement by share-based payment award, options, exercises in period mean?
The number of common shares issued as a result of employees exercising their vested stock options. This activity directly impacts the total weighted-average shares outstanding and reflects the conversion of incentive compensation into equity ownership.